Highly rated in
Highly rated in
Check Dr. Steven A. Schneider's experience treating your condition:
About Dr. Steven A. Schneider

Steven Schneider is an Urologist in Chesterfield, Missouri. Schneider has been practicing medicine for over 13 years and is highly rated in 26 conditions, according to our data. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, UPJ Obstruction, and Retroperitoneal Fibrosis. He is licensed to treat patients in Illinois and Missouri. Schneider is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Steven A. Schneider it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Steven A. Schneider accepts the following insurance:

  •  Ambetter
  •  Cigna
  •  Health Alliance

Call to see if your plan is accepted.
111 St. Luke's Center Dr, Suite 40 B, Chesterfield, MO 63017
Other Locations
12277 De Paul Dr, Suite 201-s, Bridgeton, MO 63044
3165 Mckelvey Rd, Bridgeton, MO 63044
Background & Education
Graduate Institution
Louisiana State University School Of Medicine In New Orleans, 2009
Urology in MO
Hospital Affiliations
SSM Health St Marys Hospital - St Louis
St Lukes Hospital
SSM Health St Joseph Hospital - St Charles
SSM Health St Clare Hospital - Fenton
SSM Health DePaul Hospital - St Louis
Barnes-Jewish St Peters Hospital
SSM Health Rehabilitation Hospital - Richmond Heights
Christian Hospital
OSF Saint Anthonys Health Center
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Total Publications

Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors